Date published: 2026-5-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rosiglitazone-d3

0.0(0)
Write a reviewAsk a question

Application:
Rosiglitazone-d3 is an agonist of PPARγ; an insulin sensitizer
Molecular Weight:
360.45
Molecular Formula:
C18H16D3N3O3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Labelled Rosiglitazone. Insulin sensitizer; binds to peroxisome proliferator activated receptor gamma (PPAR- γ).


Rosiglitazone-d3 References

  1. Rosiglitazone.  |  Balfour, JA. and Plosker, GL. 1999. Drugs. 57: 921-30; discussion 931-2. PMID: 10400405
  2. Simultaneous quantification of rosiglitazone and its two major metabolites, N-desmethyl and p-hydroxy rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.  |  Kim, KB., et al. 2009. J Chromatogr B Analyt Technol Biomed Life Sci. 877: 1951-6. PMID: 19477697
  3. Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.  |  Sanders, WG., et al. 2017. J Control Release. 264: 237-246. PMID: 28867378
  4. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.  |  Oakes, ND., et al. 1994. Diabetes. 43: 1203-10. PMID: 7926289
  5. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.  |  Cantello, BC., et al. 1994. J Med Chem. 37: 3977-85. PMID: 7966158
  6. The fate of a thiazolidinedione antidiabetic agent in rat and dog.  |  Bolton, GC., et al. 1996. Xenobiotica. 26: 627-36. PMID: 8810033

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Rosiglitazone-d3, 1 mg

sc-219992
1 mg
$330.00